Company Search:
Advanced Search
Sponsored Links
DepoMed, Inc. Company Snapshot
DepoMed, Inc. operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares DepoMed with three other companies in this sector in the United States: Cambrex Corporation (2016 sales of $490.34 million of which 100% was Human Health), 3sbio Inc ($420.43 million of which 100% was Pharmaceutical), and Emergent BioSolutions, Inc. ($488.78 million ).

Sales Analysis. During the year ended December of 2016, sales at DepoMed were $455.90 million. This is an increase of 33.0% versus 2015, when the company's sales were $342.74 million.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
DepoMed, Inc.
  Stock Performance Chart for DepoMed, Inc.
  Stock Data: Recent Stock Performance:
  Current Price (1/19/2018): 7.77
(Figures in U.S. Dollars)
1 Week -6.7%   13 Weeks -9.4%  
4 Weeks 44.2%   52 Weeks -56.3%  
DepoMed, Inc. Key Data:
  Ticker: DEPO Country: United States
  Exchanges: BSE CIN PBW PCS NAS Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2016 Sales 455,897,000
(Year Ending Jan 2017).
Employees: 490
  Currency: U.S. Dollars Market Cap: 489,614,514
  Fiscal Yr Ends: December Shares Outstanding: 63,013,451
  Share Type: Common Closely Held Shares: 767,333
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.